Sign In

Login

Password

Forgot Password ? Sign Up

CD3 (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "CD3" in Polish language version.

refsWebsite
Global rank Polish rank
17nih.gov
4th place
7th place
7doi.org
2nd place
6th place
1archive.org
6th place
33rd place

archive.org

doi.org

  • MS. Kuhns, HB. Badgandi. Piecing together the family portrait of TCR-CD3 complexes.. „Immunol Rev”. 250 (1), s. 120-43, Nov 2012. DOI: 10.1111/imr.12000. PMID: 23046126. 
  • CS. Guy, DA. Vignali. Organization of proximal signal initiation at the TCR:CD3 complex.. „Immunol Rev”. 232 (1), s. 7-21, Nov 2009. DOI: 10.1111/j.1600-065X.2009.00843.x. PMID: 19909352. 
  • ML. Dustin. Opening the frontier of the T cell surface: schlossman and goldstein.. „J Immunol”. 190 (11), s. 5343-5, Jun 2013. DOI: 10.4049/jimmunol.1300951. PMID: 23687190. 
  • BB. Au-Yeung, S. Deindl, LY. Hsu, EH. Palacios i inni. The structure, regulation, and function of ZAP-70.. „Immunol Rev”. 228 (1), s. 41-57, Mar 2009. DOI: 10.1111/j.1600-065X.2008.00753.x. PMID: 19290920. 
  • Y. Dean, F. Dépis, M. Kosco-Vilbois. Combination therapies in the context of anti-CD3 antibodies for the treatment of autoimmune diseases.. „Swiss Med Wkly”. 142, s. w13711, 2012. DOI: 10.4414/smw.2012.13711. PMID: 23254986. 
  • A. Kaufman, KC. Herold. Anti-CD3 mAbs for treatment of type 1 diabetes.. „Diabetes Metab Res Rev”. 25 (4), s. 302-6, May 2009. DOI: 10.1002/dmrr.933. PMID: 19319985. 
  • C. Penaranda, Q. Tang, JA. Bluestone. Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells.. „J Immunol”. 187 (4), s. 2015-22, Aug 2011. DOI: 10.4049/jimmunol.1100713. PMID: 21742976. 

nih.gov

ncbi.nlm.nih.gov

  • MS. Kuhns, HB. Badgandi. Piecing together the family portrait of TCR-CD3 complexes.. „Immunol Rev”. 250 (1), s. 120-43, Nov 2012. DOI: 10.1111/imr.12000. PMID: 23046126. 
  • CS. Guy, DA. Vignali. Organization of proximal signal initiation at the TCR:CD3 complex.. „Immunol Rev”. 232 (1), s. 7-21, Nov 2009. DOI: 10.1111/j.1600-065X.2009.00843.x. PMID: 19909352. 
  • CD247 CD247 molecule [Homo sapiens (human) - Gene - NCBI]. [dostęp 2013-05-25].
  • P. Kung, G. Goldstein, EL. Reinherz, SF. Schlossman. Monoclonal antibodies defining distinctive human T cell surface antigens.. „Science”. 206 (4416), s. 347-9, Oct 1979. PMID: 314668. 
  • JP. Van Wauwe, JR. De Mey, JG. Goossens. OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties.. „J Immunol”. 124 (6), s. 2708-13, Jun 1980. PMID: 6966296. 
  • W. de Cock, J. de Cree, H. Verhaegen. Enumeration of human peripheral T lymphocytes with E-rosettes and OKT3. PAN monoclonal antibody: a close correlation.. „Thymus”. 2 (3), s. 133-7, Dec 1980. PMID: 7008282. 
  • TW. Chang, PC. Kung, SP. Gingras, G. Goldstein. Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells?. „Proc Natl Acad Sci U S A”. 78 (3), s. 1805-8, Mar 1981. PMID: 6165018. 
  • ML. Dustin. Opening the frontier of the T cell surface: schlossman and goldstein.. „J Immunol”. 190 (11), s. 5343-5, Jun 2013. DOI: 10.4049/jimmunol.1300951. PMID: 23687190. 
  • CD3G CD3g molecule, gamma (CD3-TCR complex) [Homo sapiens (human) - Gene - NCBI]. [dostęp 2013-05-25].
  • CD3D CD3d molecule, delta (CD3-TCR complex) [Homo sapiens (human) - Gene - NCBI]. [dostęp 2013-05-25].
  • LK. Clayton, L. D'Adamio, FD. Howard, M. Sieh i inni. CD3 eta and CD3 zeta are alternatively spliced products of a common genetic locus and are transcriptionally and/or post-transcriptionally regulated during T-cell development.. „Proc Natl Acad Sci U S A”. 88 (12), s. 5202-6, Jun 1991. PMID: 1828894. 
  • C. Gerloff, R. Knoth, B. Volk. Cytoplasmic expression of the leu-4 (CD3) antigen in developing Purkinje cells in the rat cerebellum.. „Neuropathol Appl Neurobiol”. 19 (4), s. 313-23, Aug 1993. PMID: 8232751. 
  • BB. Au-Yeung, S. Deindl, LY. Hsu, EH. Palacios i inni. The structure, regulation, and function of ZAP-70.. „Immunol Rev”. 228 (1), s. 41-57, Mar 2009. DOI: 10.1111/j.1600-065X.2008.00753.x. PMID: 19290920. 
  • Y. Dean, F. Dépis, M. Kosco-Vilbois. Combination therapies in the context of anti-CD3 antibodies for the treatment of autoimmune diseases.. „Swiss Med Wkly”. 142, s. w13711, 2012. DOI: 10.4414/smw.2012.13711. PMID: 23254986. 
  • A. Kaufman, KC. Herold. Anti-CD3 mAbs for treatment of type 1 diabetes.. „Diabetes Metab Res Rev”. 25 (4), s. 302-6, May 2009. DOI: 10.1002/dmrr.933. PMID: 19319985. 
  • C. Penaranda, Q. Tang, JA. Bluestone. Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells.. „J Immunol”. 187 (4), s. 2015-22, Aug 2011. DOI: 10.4049/jimmunol.1100713. PMID: 21742976. 
  • JJ. van Dongen, GW. Krissansen, IL. Wolvers-Tettero, WM. Comans-Bitter i inni. Cytoplasmic expression of the CD3 antigen as a diagnostic marker for immature T-cell malignancies.. „Blood”. 71 (3), s. 603-12, Mar 1988. PMID: 3278747.